Speakers
Anna B. Berry, MD
Scientific Director of Personalized Medicine
Swedish Cancer Institute
Swedish Cancer Institute
Timothy L. Cannon, MD
Medical Oncologist and Clinical Director, Molecular Tumor Board and Personalized Medicine Initiative
Inova Schar Cancer Institute
Inova Schar Cancer Institute
Jennifer Levin Carter, MD, MPH
Chief Medical Officer and Founder
N-of-One
N-of-One
Amanda Cashin, PhD
Co-Founder and Head
Illumina Accelerator
Illumina Accelerator
Anita J. Chawla, PhD
Managing Principal
Analysis Group
Analysis Group
Kalidip "KC" Choudhury, PhD
Vice President, Business Development
XBiotech
XBiotech
Nicholas Donoghoe, MD
Partner
McKinsey & Company
McKinsey & Company
John Doulis, MD
Chief Informatics and Information Officer
MedCare Investment Funds
MedCare Investment Funds
Nicholas C. Dracopoli, PhD
Vice President and Head of Oncology Biomarkers
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Leeland Ekstrom, PhD
Managing Director, BioVU Partnerships
Vanderbilt University Medical Center
Vanderbilt University Medical Center
Gregory Frank, PhD
Former Director, Business Development
23andMe
23andMe
Mark Frasier, PhD
Senior Vice President, Research Programs
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research
Gary (Yuan) Gao, PhD
Co-Founder, President and Chief Executive Officer
Med Data Quest, Inc.
Med Data Quest, Inc.
Matt Gardner
Founder and Chief Executive Officer
California Technology Council
California Technology Council
Pamela Garzone, PhD
Vice President, Early Oncology Development and Clinical Research
Pfizer
Pfizer
Manuel J. Glynias
President and Chief Executive Officer
GenomOncology
GenomOncology
Sally A. Howard, JD
Head of Regulatory Affairs and Policy
Human Longevity, Inc.
Human Longevity, Inc.
Lucian Iancovici, MD
General Partner
dRx Capital AG
dRx Capital AG
Justin Kao
Co-Founder and Senior Vice President of Business Development and Partnerships
Helix
Helix
Jeffrey S. Karan
Managing Partner
WaveEdge Capital
WaveEdge Capital
David Litwack, PhD
Personalized Medicine Staff, Center for Devices and Radiological Health
FDA
FDA
Tara Maddala, PhD
Head of Biostatistics and Data Management
GRAIL, Inc.
GRAIL, Inc.
Maurie Markman, MD
President of Medicine and Science
Cancer Treatment Centers of America
Cancer Treatment Centers of America
Mark McCoy, MBA
Senior Director, Reimbursement
Guardant Health
Guardant Health
Christine Meda
Chief Business Officer
IncellDx
IncellDx
Nick Naclerio, PhD
Founder and Managing Partner
Illumina Ventures
Illumina Ventures
Aaron Nelson, MD, PhD
General Partner
dRx Capital AG
dRx Capital AG
Brad Perkins, MD
Chief Medical Officer
Human Longevity, Inc.
Human Longevity, Inc.
Samuel D. Riccitelli
Former President and Chief Executive Officer
Signal Genetics
Signal Genetics
Beni Surpin
Partner
Foley & Lardner LLP
Foley & Lardner LLP
Amber Trivedi, MS, CGC
Senior Vice President, Market Development and Innovation
InformedDNA
InformedDNA
Pieter van Rooyen, PhD
President and Chief Executive Officer
Edico Genome
Edico Genome
Ashley Van Zeeland, PhD, MBA
Chief Technology Officer
Human Longevity, Inc.
Human Longevity, Inc.
Judith A. Waltz
Partner
Foley & Lardner LLP
Foley & Lardner LLP
Christopher J. Wells, MPA
Director, Communications
Personalized Medicine Coalition
Personalized Medicine Coalition